A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection Journal Article


Authors: Jarnagin, W. R.; Gonen, M.; Maithel, S. K.; Fong, Y.; Dangelica, M. I.; DeMatteo, R. P.; Grant, F.; Wuest, D.; Kundu, K.; Blumgart, L. H.; Fischer, M.
Article Title: A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection
Abstract: Background: Hepatic resection is the most effective treatment for many malignant and benign conditions affecting the liver and biliary tree. Despite improvements, major partial hepatectomy can be associated with considerable blood loss and transfusion requirements. Transfusion of allogeneic blood products, although potentially life-saving, is associated with many potential complications. The primary aim of this study was to determine if acute normovolemic hemodilution (ANH), an established blood conservation technique, reduces the requirement for allogeneic red cell transfusions in patients undergoing major hepatic resection. Methods: One hundred thirty patients undergoing major hepatic resection (≤3 segments) were prospectively randomized to undergo either ANH or standard anesthetic management (STD). In the ANH group, intraoperative blood collection was performed to a target hemoglobin of 8.0 g/dL. Low central venous pressure anesthetic technique was used intraoperatively for both groups. A standardized transfusion protocol was applied to all patients intraoperatively and throughout the hospital stay. Results: From April 2004 to March 2007, 63 patients were randomized to ANH and 67 to STD. Demographics, diagnoses, liver function, extent of resection, intraoperative blood loss, operative time, incidence and grade of complications, and length of hospital stay were similar between the 2 groups. ANH reduced the overall allogeneic red cell transfusion rate by 50% compared with STD [12.7% (n = 8) vs. 25.4% (n = 17), respectively; P = 0.067. ANH patients were less often transfused intraoperatively (n = 1, 1.6%) compared with the STD group (n = 7, 10.4%) (P = 0.036), had higher postoperative hemoglobin levels (P = 0.01), and tended to require fewer red cell units overall (28 vs. 47 units). In patients with intraoperative blood loss ≤ 800 mL, ANH reduced not only the allogeneic red cell transfusion rate (18.2% vs. 42.4%, P = 0.045) but also the proportion of patients requiring fresh frozen plasma (21.1% vs. 48.3%, P = 0.025). Conclusion: For patients undergoing major liver resection, ANH is safe, effectively reduces the need for allogeneic transfusions, and should be considered for routine use. Given the modest transfusion rate in the STD arm, future efforts should attempt to target ANH use to patients most likely to benefit. © 2008 Lippincott Williams & Wilkins.
Keywords: adult; controlled study; treatment outcome; aged; aged, 80 and over; middle aged; major clinical study; clinical trial; ascites; liver function; comparative study; preoperative care; methodology; prospective study; intraoperative care; prospective studies; demography; controlled clinical trial; randomized controlled trial; fluid therapy; incidence; hemoglobin; hemoglobin blood level; postoperative complication; liver failure; liver metastasis; hospitalization; hemodilution; blood sampling; intraoperative period; operation duration; patient safety; blood transfusion; liver resection; intermethod comparison; hepatectomy; liver cancer; postoperative hemorrhage; erythrocyte transfusion; wound infection; time series analysis; peroperative care; partial hepatectomy; heart muscle ischemia; bile duct cancer; anesthesia; central venous pressure; fresh frozen plasma; blood conservation; perihepatic fluid collection; blood autotransfusion; blood transfusion, autologous
Journal Title: Annals of Surgery
Volume: 248
Issue: 3
ISSN: 0003-4932
Publisher: Lippincott Williams & Wilkins  
Date Published: 2008-01-01
Start Page: 360
End Page: 368
Language: English
DOI: 10.1097/SLA.0b013e318184db08
PUBMED: 18791356
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 12" - "Export Date: 17 November 2011" - "CODEN: ANSUA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mary Ellen Fischer
    30 Fischer
  2. Florence Grant
    15 Grant
  3. Leslie H Blumgart
    352 Blumgart
  4. David L Wuest
    40 Wuest
  5. Ronald P DeMatteo
    637 DeMatteo
  6. Mithat Gonen
    1031 Gonen
  7. Shishir Kumar Maithel
    11 Maithel
  8. William R Jarnagin
    907 Jarnagin
  9. Yuman Fong
    775 Fong
  10. Kuhali Kundu
    1 Kundu